Publication | Closed Access
Oral cinacalcet HCI (AMG 073) for the treatment of hemodialysis patients with secondary hyperparathyroidism (HPT): Results of a European/Australian-Phase 3 study
10
Citations
0
References
2003
Year
HemodialysisUrologyHemodialysis PatientsKidney FailureChronic Kidney DiseaseParathyroid HormoneParathyroid DiseaseAmg 073Dialysis TherapyMedicineRenal PharmacologyNephrologyOral Cinacalcet Hci
No additional data available for this publication yet. Check back later!